US Stock MarketDetailed Quotes

TELA TELA Bio

Watchlist
  • 2.610
  • +0.010+0.38%
Close Feb 14 16:00 ET
102.80MMarket Cap-1.54P/E (TTM)

About TELA Bio Company

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Company Profile

SymbolTELA
Company NameTELA Bio
Listing DateNov 8, 2019
Issue Price13.00
Founded2012
CEOMr. Anthony Koblish
MarketNASDAQ
Employees227
Fiscal Year Ends12-31
Address1 Great Valley Parkway,Suite 24
CityMalvern
ProvincePennsylvania
CountryUnited States of America
Zip Code19355
Phone1-484-320-2930
Websitehttp://www.telabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Anthony Koblish
  • Director, President and Chief Executive Officer
  • 2.37M
  • Peter C. Murphy
  • Chief Commercial Officer
  • --
  • Roberto Cuca
  • Chief Operating Officer and Chief Financial Officer
  • 1.06M
  • Paul Talmo
  • Chief Technology Officer
  • 962.24K
  • Gregory A. Firestone
  • Chief Business Officer
  • --
  • Megan Smeykal
  • Chief Accounting Officer and Corporate Controller
  • --
  • Doug Evans
  • Chairman of the Board
  • 161.09K
  • Federica O'Brien
  • Independent Director
  • 133.59K
  • Kurt Azarbarzin
  • Independent Director
  • 121.09K
  • Vincent J. Burgess
  • Independent Director
  • 128.59K
  • Lisa N. Colleran
  • Independent Director
  • 133.59K

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025